These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 7869773

  • 1. Establishment and characterization of an immature human megakaryoblastic cell line, MEG-A2.
    Abe A, Emi N, Kato H, Adachi K, Murate T, Saga S, Ogura M, Kojima T, Tanimoto M, Morishita N.
    Leukemia; 1995 Feb; 9(2):341-9. PubMed ID: 7869773
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
    Tsuyuoka R, Takahashi T, Suzuki A, Sasaki Y, Nakamura K, Fukumoto M, Ohmori K, Ohno Y, Nakao K.
    Stem Cells; 1995 Jan; 13(1):54-64. PubMed ID: 7719248
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Establishment and characterization of a novel human monocytic leukemia cell line (KP-1) expressing scavenger receptor.
    Adachi N, Takaki K, Nakamura R, Ohta T, Naito M, Horiuchi S, Matsuda I.
    Pediatr Res; 1993 Sep; 34(3):258-64. PubMed ID: 8134164
    [Abstract] [Full Text] [Related]

  • 6. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T, Ylänne J, Virtanen I.
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [Abstract] [Full Text] [Related]

  • 7. Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability.
    Itano M, Tsuchiya S, Minegishi N, Fujie H, Minegishi M, Morita S, Yambe T, Ohashi Y, Masuda T, Koike T.
    Exp Hematol; 1995 Nov; 23(12):1301-9. PubMed ID: 7589286
    [Abstract] [Full Text] [Related]

  • 8. A novel Philadelphia chromosome-positive cell line with multipotential properties.
    Nakayama T, Tohyama K, Imamura S, Yoshida A, Fukushima T, Tsutani H, Nakamura T, Wano Y, Ohno Y, Ueda T.
    Anticancer Res; 1999 Nov; 19(1A):349-56. PubMed ID: 10226566
    [Abstract] [Full Text] [Related]

  • 9. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
    Gore SD, Amin S, Weng LJ, Civin CI.
    Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
    [Abstract] [Full Text] [Related]

  • 10. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H, Zaborski M, Graf G, Ludwig WD, Drexler HG.
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [Abstract] [Full Text] [Related]

  • 11. A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
    Hirata J, Sato H, Takahira H, Shiokawa S, Endo T, Nishimura J, Katsuno M, Masuda S, Sasaki R, Fukumaki Y.
    Leukemia; 1990 May; 4(5):365-72. PubMed ID: 2167410
    [Abstract] [Full Text] [Related]

  • 12. MEG-01s cells have receptors for and respond to IL-3, IL-6, and SCF.
    Kellar KL, Hooper WC, Benson JM.
    Exp Hematol; 1995 Jun; 23(6):557-64. PubMed ID: 7539384
    [Abstract] [Full Text] [Related]

  • 13. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
    Dilloo D, Hanenberg H, Lion T, Burdach S.
    Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
    [Abstract] [Full Text] [Related]

  • 14. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S, Bregni M, Bonsi L, Sklenar I, Bagnara GP, Bonadonna G, Gianni AM.
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [Abstract] [Full Text] [Related]

  • 15. Aberrant growth of granulocyte-macrophage progenitors in juvenile chronic myelogenous leukemia in serum-free culture.
    Sawai N, Koike K, Ito S, Okumura N, Kamijo T, Shiohara M, Amano Y, Tsuji K, Nakahata T, Oda M.
    Exp Hematol; 1996 Feb; 24(2):116-22. PubMed ID: 8641332
    [Abstract] [Full Text] [Related]

  • 16. Expression of prostacyclin receptor in human megakaryocytes.
    Sasaki Y, Takahashi T, Tanaka I, Nakamura K, Okuno Y, Nakagawa O, Narumiya S, Nakao K.
    Blood; 1997 Aug 01; 90(3):1039-46. PubMed ID: 9242534
    [Abstract] [Full Text] [Related]

  • 17. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells.
    Drexler HG.
    Leukemia; 1996 Apr 01; 10(4):588-99. PubMed ID: 8618433
    [Abstract] [Full Text] [Related]

  • 18. Cellular characteristics of chronic myelocytic leukemia basophilic crisis cells: phenotype, responsiveness to and receptor gene expression for various kinds of growth factors and cytokines.
    Shimizu N, Kita K, Masuya M, Nishii K, Matsuoka N, Morita N, Miwa H, Shirakawa S.
    Exp Hematol; 1993 Jan 01; 21(1):119-25. PubMed ID: 7678084
    [Abstract] [Full Text] [Related]

  • 19. Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-181).
    Estrov Z, Talpaz M, Zipf TF, Kantarjian HM, Ku S, Ouspenskaia MV, Hirsch-Ginsberg C, Huh Y, Yee G, Kurzrock R.
    J Cell Physiol; 1996 Mar 01; 166(3):618-30. PubMed ID: 8600166
    [Abstract] [Full Text] [Related]

  • 20. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
    Akashi K, Mizuno S, Harada M, Kimura N, Kinjyo M, Shibuya T, Shimoda K, Takeshita M, Okamura S, Matsumoto I.
    Exp Hematol; 1993 Jun 01; 21(6):743-8. PubMed ID: 7684698
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.